Biofabrication approaches and regulatory framework of metastatic tumor-on-a-chip models for precision oncology.

Authors:
Nieto D; Jiménez G; Moroni L; López-Ruiz E; Gálvez-Martín P and 1 more

Journal:
Med Res Rev

Publication Year: 2022

DOI:
10.1002/med.21914

PMCID:
PMC9545141

PMID:
35707911

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Med Res Rev

Abbreviation: Med Res Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Cardiovascular therapeutics: A new potential for anxiety treatment?
Repova K; Aziriova S; Krajcirovicova K and 1 more (2022) - Transparency Score: 2/6
Mutations of TRPM8 channels: Unraveling the molecular basis of activation by cold and ligands.
Plaza-Cayón A; González-Muñiz R; Martín-Martínez M. (2022) - Transparency Score: 3/6
Skin cancer, including related pathways and therapy and the role of luteolin derivatives as potenti…
Juszczak AM; Wöelfle U; Končić MZ and 1 more (2022) - Transparency Score: 3/6
Discovery of K<sub>V</sub> 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenge…
Gubič Š; Hendrickx LA; Toplak Ž and 7 more (2021) - Transparency Score: 3/6
Mechanism of activation and the rewired network: New drug design concepts.
Nussinov R; Zhang M; Maloney R and 4 more (2021) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST The authors declare no conflict of interest."

Evidence found in paper:

"This study was funded by Consejería de Salud y Familias de la Junta de Andalucía (project no. PIN‐0224‐2019), by the Consejería de Economía, Conocimiento, Empresas y Universidad de la Junta de Andalucía (A‐CTS‐180‐UGR20, P18‐FR‐2470, B‐CTS‐230‐UGR18, and SOMM17/6109/UGR, FEDER Funds), by the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III (FEDER funds, Projects number PIE16/00045 and DTS19/00143), and from the Chair "Doctors Galera‐Requena in cancer stem cell research" (CMC‐CTS963). G. J. acknowledges the posdoctoral fellowship from Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020—FEDER funds—Ref: DOC_01574)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025